Daiwa Securities Group Inc. Cara Therapeutics, Inc. Transaction History

Daiwa Securities Group Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	BUY	$11.55 - $16.06 $796 - $1,108	69 Added 66.99%	172 $3,000
Q4 2020 Feb 04, 2021	SELL	$12.72 - $16.16 $2,035 - $2,585	-160 Reduced 60.84%	103 $2,000
Q4 2019 Jan 31, 2020	SELL	$16.11 - $25.98 $531 - $857	-33 Reduced 11.15%	263 $4,000
Q3 2019 Nov 04, 2019	BUY	$18.28 - $26.91 $822 - $1,210	45 Added 17.93%	296 $5,000
Q1 2019 Apr 26, 2019	BUY	$14.41 - $19.64 $1,023 - $1,394	71 Added 39.44%	251 $5,000
Q1 2018 May 02, 2018	BUY	$11.77 - $16.08 $2,118 - $2,894	180 New	180 $2,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.